LIPO logo

Lipella Pharmaceuticals Inc. Common Stock


LIPO: Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's lead product candidates include LP-10 and LP-310.


Show LIPO Financials

Consumer Interest
SEC Filings

Recent trades of LIPO by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by LIPO's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Delivery of agents using metastable liposomes Jun. 14, 2022
  • Patent Title: Delivery of agents using metastable liposomes May. 05, 2020
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of LIPO in WallStreetBets Daily Discussion


Recent insights relating to LIPO

CNBC Recommendations

Recent picks made for LIPO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LIPO

Corporate Flights

Flights by private jets registered to LIPO